BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14608530)

  • 21. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
    Ozcan HEA; Anuk T; Ozden O
    Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
    Siahpush SH; Vaughan TL; Lampe JN; Freeman R; Lewis S; Odze RD; Blount PL; Ayub K; Rabinovitch PS; Reid BJ; Chen C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2387-95. PubMed ID: 18006928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus.
    Couvelard A; Paraf F; Vidaud D; Dubois S; Vidaud M; Fléjou JF; Degott C
    Virchows Arch; 2004 Sep; 445(3):279-84. PubMed ID: 15309632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia.
    Anders M; Rösch T; Küster K; Becker I; Höfler H; Stein HJ; Meining A; Wiedenmann B; Sarbia M
    Cancer Gene Ther; 2009 Jun; 16(6):508-15. PubMed ID: 19132065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett's esophagus: Case series and findings.
    Marketkar S; Li D; Yang D; Cao W
    World J Gastroenterol; 2017 Feb; 23(8):1338-1344. PubMed ID: 28293080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
    Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
    Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD44 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pages C; Paraf F; Dubois S; Belghiti J; Fléjou JF
    Histopathology; 1998 Jan; 32(1):7-14. PubMed ID: 9522210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
    Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ
    Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
    Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma.
    Morales CP; Lee EL; Shay JW
    Cancer; 1998 Aug; 83(4):652-9. PubMed ID: 9708927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
    Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.
    Huhta H; Helminen O; Palomäki S; Kauppila JH; Saarnio J; Lehenkari PP; Karttunen TJ
    Oncotarget; 2017 Apr; 8(14):22894-22902. PubMed ID: 28206968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L in Barrett's esophagus with dysplasia and adenocarcinoma.
    Popnikolov NK; Gatalica Z; Adegboyega PA; Norris BA; Pasricha PJ
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):161-5. PubMed ID: 16785783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incipient angiogenesis in Barrett's epithelium and lymphangiogenesis in Barrett's adenocarcinoma.
    Auvinen MI; Sihvo EI; Ruohtula T; Salminen JT; Koivistoinen A; Siivola P; Rönnholm R; Rämö JO; Bergman M; Salo JA
    J Clin Oncol; 2002 Jul; 20(13):2971-9. PubMed ID: 12089227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-erb-B2 and Bcl-xl protein expression in Barrett's oesophagus in correlation with morphological parameters.
    Barwijuk-Machała M; Reszeć J; Kemona A; Sobaniec-Lotowska M
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():40-2. PubMed ID: 15638369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.